7Some differences were found in the perceptions and behaviors of hematologists and oncologists regarding the prognostic assessment of CLL/SLL, the choice of treatment options, the clinical use of BTK inhibitors, etc. The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.